These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9523225)

  • 21. Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia with different clinical stages.
    Gopcsa L; Barta A; Banyai A; Foldi J; Kalasz L; Pajor L; Gidali J; Regeczy N; Paloczi K
    Acta Haematol; 2001; 106(3):100-5. PubMed ID: 11713374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The M.D. Anderson Cancer Center experience with interferon-alpha therapy in chronic myelogenous leukaemia.
    Talpaz M; Kantarjian HM; O'Brien S; Kurzrock R
    Baillieres Clin Haematol; 1997 Jun; 10(2):291-305. PubMed ID: 9376665
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon alpha in the treatment of chronic myelogenous leukemia.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 25. Questions raised by the Benelux CML Study Group: results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha2b for chronic myeloid leukemia.
    Kantarjian HM; Talpaz M
    Blood; 1998 Oct; 92(8):2984-7. PubMed ID: 9763593
    [No Abstract]   [Full Text] [Related]  

  • 26. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
    Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.
    Sacchi S; Kantarjian HM; O'Brien S; Cortes J; Rios MB; Giles FJ; Beran M; Koller CA; Keating MJ; Talpaz M
    Cancer; 1999 Dec; 86(12):2632-41. PubMed ID: 10594858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.
    Carella AM
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; O'Brien S; Beran M; Koller C; Pierce S; Kornblau S; Estey E; Keating MJ; Talpaz M
    Leukemia; 1997 Oct; 11(10):1610-6. PubMed ID: 9324278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
    Berger U; Engelich G; Maywald O; Pfirrmann M; Hochhaus A; Reiter A; Metzgeroth G; Gnad U; Hasford J; Heinze B; Heimpel H; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Hehlmann R;
    Leukemia; 2003 Sep; 17(9):1820-6. PubMed ID: 12970782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current aspects of drug therapy in Philadelphia-positive CML: correlation of tumor burden with survival.
    Hehlmann R; Heimpel H
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():161-7. PubMed ID: 8951787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.
    Chiba A; Toya T; Mizuno H; Tokushige J; Nakamura F; Nakazaki K; Kurokawa M
    Int J Hematol; 2018 Dec; 108(6):640-646. PubMed ID: 30078165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving approaches with interferon alfa in chronic myelogenous leukemia.
    Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Caricchi P
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):26-7. PubMed ID: 8235701
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeted chronic myeloid leukemia therapy: Seeking a cure.
    Fausel C
    Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S9-15. PubMed ID: 18056932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current therapy of chronic myelogenous leukemia.
    Garcia-Manero G; Talpaz M; Kantarjian HM
    Intern Med; 2002 Apr; 41(4):254-64. PubMed ID: 11993784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic myeloid leukemia].
    Hehlmann R
    Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
    Kantarjian HM; Talpaz M
    Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current therapy concepts in chronic myeloid leukemia. Study IV of the German CML Study Group].
    Hochhaus A; Berger U; Reiter A; Engelich G; Lahaye T; Kreil S; Merx K; Müller MC; Hehlmann R
    Internist (Berl); 2002 Oct; 43(10):1228, 1231-8, 1241-4. PubMed ID: 12524904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.